▶ 調査レポート

OTC薬の世界市場(~2026年)

• 英文タイトル:Global Over-the-Counter Drug Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。OTC薬の世界市場(~2026年) / Global Over-the-Counter Drug Market Size, Status and Forecast 2020-2026 / MRC2-11QY04133資料のイメージです。• レポートコード:MRC2-11QY04133
• 出版社/出版日:QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、98ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療、製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料はOTC薬のグローバル市場について調査・分析したレポートです。種類別(栄養補助食品、胃腸薬、鎮痛剤、呼吸器系薬)市場規模、用途別(病院、薬局、その他)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別OTC薬の競争状況、市場シェア
・世界のOTC薬市場:種類別市場規模 2015年-2020年(栄養補助食品、胃腸薬、鎮痛剤、呼吸器系薬)
・世界のOTC薬市場:種類別市場規模予測 2021年-2026年(栄養補助食品、胃腸薬、鎮痛剤、呼吸器系薬)
・世界のOTC薬市場:用途別市場規模 2015年-2020年(病院、薬局、その他)
・世界のOTC薬市場:用途別市場規模予測 2021年-2026年(病院、薬局、その他)
・北米のOTC薬市場分析:米国、カナダ
・ヨーロッパのOTC薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのOTC薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のOTC薬市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのOTC薬市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Bayer HealthCare、GSK、Johnson & Johnson、Pfizer、Sanofi、Abbott、Achelios Therapeutics、American Health、Amgen、Arena Pharmaceuticals
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

OTC drugs are medicines that can be bought without a prescription from a doctor.
The lenient regulatory framework and the availability of several distribution channels to be some of the major factors that will have a positive impact on the growth of this market in the coming years.

Market Analysis and Insights: Global Over-the-Counter Drug Market
The global Over-the-Counter Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Over-the-Counter Drug Scope and Market Size
Over-the-Counter Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Over-the-Counter Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Bayer HealthCare
GSK
Johnson & Johnson
Pfizer
Sanofi
Abbott
Achelios Therapeutics
American Health
Amgen
Arena Pharmaceuticals

Market segment by Type, the product can be split into
Dietary Supplements
Gastrointestinal Drugs
Pain Medications
Respiratory Drugs
Market segment by Application, split into
The Hospital
The Pharmacy
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Over-the-Counter Drug Revenue
1.4 Market by Type
1.4.1 Global Over-the-Counter Drug Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Dietary Supplements
1.4.3 Gastrointestinal Drugs
1.4.4 Pain Medications
1.4.5 Respiratory Drugs
1.5 Market by Application
1.5.1 Global Over-the-Counter Drug Market Share by Application: 2020 VS 2026
1.5.2 The Hospital
1.5.3 The Pharmacy
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Over-the-Counter Drug Market Perspective (2015-2026)
2.2 Global Over-the-Counter Drug Growth Trends by Regions
2.2.1 Over-the-Counter Drug Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Over-the-Counter Drug Historic Market Share by Regions (2015-2020)
2.2.3 Over-the-Counter Drug Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Over-the-Counter Drug Market Growth Strategy
2.3.6 Primary Interviews with Key Over-the-Counter Drug Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Over-the-Counter Drug Players by Market Size
3.1.1 Global Top Over-the-Counter Drug Players by Revenue (2015-2020)
3.1.2 Global Over-the-Counter Drug Revenue Market Share by Players (2015-2020)
3.1.3 Global Over-the-Counter Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Over-the-Counter Drug Market Concentration Ratio
3.2.1 Global Over-the-Counter Drug Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Over-the-Counter Drug Revenue in 2019
3.3 Over-the-Counter Drug Key Players Head office and Area Served
3.4 Key Players Over-the-Counter Drug Product Solution and Service
3.5 Date of Enter into Over-the-Counter Drug Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Over-the-Counter Drug Historic Market Size by Type (2015-2020)
4.2 Global Over-the-Counter Drug Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Over-the-Counter Drug Market Size by Application (2015-2020)
5.2 Global Over-the-Counter Drug Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Over-the-Counter Drug Market Size (2015-2020)
6.2 Over-the-Counter Drug Key Players in North America (2019-2020)
6.3 North America Over-the-Counter Drug Market Size by Type (2015-2020)
6.4 North America Over-the-Counter Drug Market Size by Application (2015-2020)

7 Europe
7.1 Europe Over-the-Counter Drug Market Size (2015-2020)
7.2 Over-the-Counter Drug Key Players in Europe (2019-2020)
7.3 Europe Over-the-Counter Drug Market Size by Type (2015-2020)
7.4 Europe Over-the-Counter Drug Market Size by Application (2015-2020)

8 China
8.1 China Over-the-Counter Drug Market Size (2015-2020)
8.2 Over-the-Counter Drug Key Players in China (2019-2020)
8.3 China Over-the-Counter Drug Market Size by Type (2015-2020)
8.4 China Over-the-Counter Drug Market Size by Application (2015-2020)

9 Japan
9.1 Japan Over-the-Counter Drug Market Size (2015-2020)
9.2 Over-the-Counter Drug Key Players in Japan (2019-2020)
9.3 Japan Over-the-Counter Drug Market Size by Type (2015-2020)
9.4 Japan Over-the-Counter Drug Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Over-the-Counter Drug Market Size (2015-2020)
10.2 Over-the-Counter Drug Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Over-the-Counter Drug Market Size by Type (2015-2020)
10.4 Southeast Asia Over-the-Counter Drug Market Size by Application (2015-2020)

11 India
11.1 India Over-the-Counter Drug Market Size (2015-2020)
11.2 Over-the-Counter Drug Key Players in India (2019-2020)
11.3 India Over-the-Counter Drug Market Size by Type (2015-2020)
11.4 India Over-the-Counter Drug Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Over-the-Counter Drug Market Size (2015-2020)
12.2 Over-the-Counter Drug Key Players in Central & South America (2019-2020)
12.3 Central & South America Over-the-Counter Drug Market Size by Type (2015-2020)
12.4 Central & South America Over-the-Counter Drug Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Bayer HealthCare
13.1.1 Bayer HealthCare Company Details
13.1.2 Bayer HealthCare Business Overview
13.1.3 Bayer HealthCare Over-the-Counter Drug Introduction
13.1.4 Bayer HealthCare Revenue in Over-the-Counter Drug Business (2015-2020))
13.1.5 Bayer HealthCare Recent Development
13.2 GSK
13.2.1 GSK Company Details
13.2.2 GSK Business Overview
13.2.3 GSK Over-the-Counter Drug Introduction
13.2.4 GSK Revenue in Over-the-Counter Drug Business (2015-2020)
13.2.5 GSK Recent Development
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Details
13.3.2 Johnson & Johnson Business Overview
13.3.3 Johnson & Johnson Over-the-Counter Drug Introduction
13.3.4 Johnson & Johnson Revenue in Over-the-Counter Drug Business (2015-2020)
13.3.5 Johnson & Johnson Recent Development
13.4 Pfizer
13.4.1 Pfizer Company Details
13.4.2 Pfizer Business Overview
13.4.3 Pfizer Over-the-Counter Drug Introduction
13.4.4 Pfizer Revenue in Over-the-Counter Drug Business (2015-2020)
13.4.5 Pfizer Recent Development
13.5 Sanofi
13.5.1 Sanofi Company Details
13.5.2 Sanofi Business Overview
13.5.3 Sanofi Over-the-Counter Drug Introduction
13.5.4 Sanofi Revenue in Over-the-Counter Drug Business (2015-2020)
13.5.5 Sanofi Recent Development
13.6 Abbott
13.6.1 Abbott Company Details
13.6.2 Abbott Business Overview
13.6.3 Abbott Over-the-Counter Drug Introduction
13.6.4 Abbott Revenue in Over-the-Counter Drug Business (2015-2020)
13.6.5 Abbott Recent Development
13.7 Achelios Therapeutics
13.7.1 Achelios Therapeutics Company Details
13.7.2 Achelios Therapeutics Business Overview
13.7.3 Achelios Therapeutics Over-the-Counter Drug Introduction
13.7.4 Achelios Therapeutics Revenue in Over-the-Counter Drug Business (2015-2020)
13.7.5 Achelios Therapeutics Recent Development
13.8 American Health
13.8.1 American Health Company Details
13.8.2 American Health Business Overview
13.8.3 American Health Over-the-Counter Drug Introduction
13.8.4 American Health Revenue in Over-the-Counter Drug Business (2015-2020)
13.8.5 American Health Recent Development
13.9 Amgen
13.9.1 Amgen Company Details
13.9.2 Amgen Business Overview
13.9.3 Amgen Over-the-Counter Drug Introduction
13.9.4 Amgen Revenue in Over-the-Counter Drug Business (2015-2020)
13.9.5 Amgen Recent Development
13.10 Arena Pharmaceuticals
13.10.1 Arena Pharmaceuticals Company Details
13.10.2 Arena Pharmaceuticals Business Overview
13.10.3 Arena Pharmaceuticals Over-the-Counter Drug Introduction
13.10.4 Arena Pharmaceuticals Revenue in Over-the-Counter Drug Business (2015-2020)
13.10.5 Arena Pharmaceuticals Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Over-the-Counter Drug Key Market Segments
Table 2. Key Players Covered: Ranking by Over-the-Counter Drug Revenue
Table 3. Ranking of Global Top Over-the-Counter Drug Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Over-the-Counter Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Dietary Supplements
Table 6. Key Players of Gastrointestinal Drugs
Table 7. Key Players of Pain Medications
Table 8. Key Players of Respiratory Drugs
Table 9. Global Over-the-Counter Drug Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Over-the-Counter Drug Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Over-the-Counter Drug Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Over-the-Counter Drug Market Share by Regions (2015-2020)
Table 13. Global Over-the-Counter Drug Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Over-the-Counter Drug Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Over-the-Counter Drug Market Growth Strategy
Table 19. Main Points Interviewed from Key Over-the-Counter Drug Players
Table 20. Global Over-the-Counter Drug Revenue by Players (2015-2020) (Million US$)
Table 21. Global Over-the-Counter Drug Market Share by Players (2015-2020)
Table 22. Global Top Over-the-Counter Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Over-the-Counter Drug as of 2019)
Table 23. Global Over-the-Counter Drug by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Over-the-Counter Drug Product Solution and Service
Table 26. Date of Enter into Over-the-Counter Drug Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Over-the-Counter Drug Market Size by Type (2015-2020) (Million US$)
Table 29. Global Over-the-Counter Drug Market Size Share by Type (2015-2020)
Table 30. Global Over-the-Counter Drug Revenue Market Share by Type (2021-2026)
Table 31. Global Over-the-Counter Drug Market Size Share by Application (2015-2020)
Table 32. Global Over-the-Counter Drug Market Size by Application (2015-2020) (Million US$)
Table 33. Global Over-the-Counter Drug Market Size Share by Application (2021-2026)
Table 34. North America Key Players Over-the-Counter Drug Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Over-the-Counter Drug Market Share (2019-2020)
Table 36. North America Over-the-Counter Drug Market Size by Type (2015-2020) (Million US$)
Table 37. North America Over-the-Counter Drug Market Share by Type (2015-2020)
Table 38. North America Over-the-Counter Drug Market Size by Application (2015-2020) (Million US$)
Table 39. North America Over-the-Counter Drug Market Share by Application (2015-2020)
Table 40. Europe Key Players Over-the-Counter Drug Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Over-the-Counter Drug Market Share (2019-2020)
Table 42. Europe Over-the-Counter Drug Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Over-the-Counter Drug Market Share by Type (2015-2020)
Table 44. Europe Over-the-Counter Drug Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Over-the-Counter Drug Market Share by Application (2015-2020)
Table 46. China Key Players Over-the-Counter Drug Revenue (2019-2020) (Million US$)
Table 47. China Key Players Over-the-Counter Drug Market Share (2019-2020)
Table 48. China Over-the-Counter Drug Market Size by Type (2015-2020) (Million US$)
Table 49. China Over-the-Counter Drug Market Share by Type (2015-2020)
Table 50. China Over-the-Counter Drug Market Size by Application (2015-2020) (Million US$)
Table 51. China Over-the-Counter Drug Market Share by Application (2015-2020)
Table 52. Japan Key Players Over-the-Counter Drug Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Over-the-Counter Drug Market Share (2019-2020)
Table 54. Japan Over-the-Counter Drug Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Over-the-Counter Drug Market Share by Type (2015-2020)
Table 56. Japan Over-the-Counter Drug Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Over-the-Counter Drug Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Over-the-Counter Drug Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Over-the-Counter Drug Market Share (2019-2020)
Table 60. Southeast Asia Over-the-Counter Drug Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Over-the-Counter Drug Market Share by Type (2015-2020)
Table 62. Southeast Asia Over-the-Counter Drug Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Over-the-Counter Drug Market Share by Application (2015-2020)
Table 64. India Key Players Over-the-Counter Drug Revenue (2019-2020) (Million US$)
Table 65. India Key Players Over-the-Counter Drug Market Share (2019-2020)
Table 66. India Over-the-Counter Drug Market Size by Type (2015-2020) (Million US$)
Table 67. India Over-the-Counter Drug Market Share by Type (2015-2020)
Table 68. India Over-the-Counter Drug Market Size by Application (2015-2020) (Million US$)
Table 69. India Over-the-Counter Drug Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Over-the-Counter Drug Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Over-the-Counter Drug Market Share (2019-2020)
Table 72. Central & South America Over-the-Counter Drug Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Over-the-Counter Drug Market Share by Type (2015-2020)
Table 74. Central & South America Over-the-Counter Drug Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Over-the-Counter Drug Market Share by Application (2015-2020)
Table 76. Bayer HealthCare Company Details
Table 77. Bayer HealthCare Business Overview
Table 78. Bayer HealthCare Product
Table 79. Bayer HealthCare Revenue in Over-the-Counter Drug Business (2015-2020) (Million US$)
Table 80. Bayer HealthCare Recent Development
Table 81. GSK Company Details
Table 82. GSK Business Overview
Table 83. GSK Product
Table 84. GSK Revenue in Over-the-Counter Drug Business (2015-2020) (Million US$)
Table 85. GSK Recent Development
Table 86. Johnson & Johnson Company Details
Table 87. Johnson & Johnson Business Overview
Table 88. Johnson & Johnson Product
Table 89. Johnson & Johnson Revenue in Over-the-Counter Drug Business (2015-2020) (Million US$)
Table 90. Johnson & Johnson Recent Development
Table 91. Pfizer Company Details
Table 92. Pfizer Business Overview
Table 93. Pfizer Product
Table 94. Pfizer Revenue in Over-the-Counter Drug Business (2015-2020) (Million US$)
Table 95. Pfizer Recent Development
Table 96. Sanofi Company Details
Table 97. Sanofi Business Overview
Table 98. Sanofi Product
Table 99. Sanofi Revenue in Over-the-Counter Drug Business (2015-2020) (Million US$)
Table 100. Sanofi Recent Development
Table 101. Abbott Company Details
Table 102. Abbott Business Overview
Table 103. Abbott Product
Table 104. Abbott Revenue in Over-the-Counter Drug Business (2015-2020) (Million US$)
Table 105. Abbott Recent Development
Table 106. Achelios Therapeutics Company Details
Table 107. Achelios Therapeutics Business Overview
Table 108. Achelios Therapeutics Product
Table 109. Achelios Therapeutics Revenue in Over-the-Counter Drug Business (2015-2020) (Million US$)
Table 110. Achelios Therapeutics Recent Development
Table 111. American Health Business Overview
Table 112. American Health Product
Table 113. American Health Company Details
Table 114. American Health Revenue in Over-the-Counter Drug Business (2015-2020) (Million US$)
Table 115. American Health Recent Development
Table 116. Amgen Company Details
Table 117. Amgen Business Overview
Table 118. Amgen Product
Table 119. Amgen Revenue in Over-the-Counter Drug Business (2015-2020) (Million US$)
Table 120. Amgen Recent Development
Table 121. Arena Pharmaceuticals Company Details
Table 122. Arena Pharmaceuticals Business Overview
Table 123. Arena Pharmaceuticals Product
Table 124. Arena Pharmaceuticals Revenue in Over-the-Counter Drug Business (2015-2020) (Million US$)
Table 125. Arena Pharmaceuticals Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Over-the-Counter Drug Market Share by Type: 2020 VS 2026
Figure 2. Dietary Supplements Features
Figure 3. Gastrointestinal Drugs Features
Figure 4. Pain Medications Features
Figure 5. Respiratory Drugs Features
Figure 6. Global Over-the-Counter Drug Market Share by Application: 2020 VS 2026
Figure 7. The Hospital Case Studies
Figure 8. The Pharmacy Case Studies
Figure 9. Other Case Studies
Figure 10. Over-the-Counter Drug Report Years Considered
Figure 11. Global Over-the-Counter Drug Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Over-the-Counter Drug Market Share by Regions: 2020 VS 2026
Figure 13. Global Over-the-Counter Drug Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Over-the-Counter Drug Market Share by Players in 2019
Figure 16. Global Top Over-the-Counter Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Over-the-Counter Drug as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Over-the-Counter Drug Revenue in 2019
Figure 18. North America Over-the-Counter Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Over-the-Counter Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Over-the-Counter Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Over-the-Counter Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Over-the-Counter Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Over-the-Counter Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Over-the-Counter Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed